Alnylam Pharmaceuticals Inc (NAS:ALNY)
$ 165.72 8.3 (5.27%) Market Cap: 20.96 Bil Enterprise Value: 19.89 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 67/100

Alnylam Pharmaceuticals Inc at Bank of America Global Healthcare Conference (Virtual) Transcript

Sep 16, 2021 / 02:05PM GMT
Release Date Price: $190.2 (+1.45%)
Tazeen Ahmad
Bank of America Securities, Inc. - Analyst

Okay, good morning, everyone, and good afternoon for those of you joining from London. My name is Tazeen Ahmad. I am one of the senior mid biotech analysts here at Bank of America. It's my pleasure to welcome you once again to our global healthcare conference, London though virtual this year. We're hoping to go back in person in future years. It's my pleasure to have with me our next presenting company, Alnylam. And presenting for Alnylam this morning is, of course, a familiar face, CEO, John Maraganore. John, good morning. Thank you for joining us again.

John Maraganore
Alnylam Pharmaceuticals, Inc. - CEO

Good morning. And good afternoon to colleagues in Europe.

Tazeen Ahmad
Bank of America Securities, Inc. - Analyst

So I think at this point, there's not that many people who don't know about Alnylam. But for those who might be kind of not healthcare specialists, John, can you give a couple of minutes overview of the Company, its platforms? And then we can

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot